SingHealth Duke-NUS Academic Medical Centre will NEVER ask you to transfer money over a call. If in doubt, call the 24/7 ScamShield helpline at 1799, or visit the ScamShield website at www.scamshield.gov.sg.

NHIC Innovation to Adopt (I2Adopt)

NHIC Innovation to Adopt (I2Adopt)
Closes On
15 Oct 2025
Funding Source
External
PI Salary Support
No
ACP/SDDC Affiliation
No ACP/SDDC affiliation required
Funding Per Grant Amount
S$ 2,000,000
Qualification
Not Specified
Academic Appointment
No
Funding Period
18 months
Citizenship
Foreigner / S / PR
Call Opens
01 Jul 2025
SMC/SDC Registered
No

Objective

Innovation to Adopt (I2Adopt) provides funding support of up to $2M for the implementation and adoption of commercially viable innovations. 

Aims:

  1. Identify and evaluate implementation feasibility of innovations for adoption and scaling across public healthcare clusters in Singapore.
  2. Engage clusters, clinicians, policy divisions to understand barriers to adoption and encourage commitment to adoption/ scaling if barriers are addressed.
  3. Strategies and resources required to address barriers to adoption/ scaling.

Funding Details

a) Up to $2 million (including institutional co-funding). The co-funding requirement is listed in the table below. Indirect costs are not provided for this grant.

I2Adopt Projects Co-Funding Requirement  
Collaborative projects with partner(s) from one different cluster 20%
Collaborative projects with partners from two different clusters 10%

b) Funding duration: 18 months.

c) Funding criteria:

  • Grant applications that emphasise the following aspects are considered for funding:
  • Well-defined unmet healthcare need incorporating Appropriate & Value-Based Care (AVBC) principles.
  • Clear deployment and product development strategy/ roadmap.
  • Fair market assessment of technology conducted beforehand.
  • Solution must (or in queue to be prioritised) in the institutions’ IT and other workplans.
  • If applicable and necessary for implementation and scaling, solution must have received regulatory approval.
  • Potential to result in reduced healthcare costs, improved clinical outcome and eventual adoption by the healthcare system.
  • Cross cluster deployment.

Eligbility Criteria

The Principal Investigator (PI) must hold a primary appointment in and be under the employment of a public healthcare institution or academic medical school in Singapore.

Considerations for project gearing toward clinical adoption:

  • Ability to implement a solution prioritised by your Cluster in (i) at least three sites and (ii) in one other cluster(s).
  • Approved/ registered or close to regulatory approval or registration; ethics submission or approval (as applicable).

Commercial position: Industry partner’s commitment to pilot at scale for eventual implementation and adoption cross cluster. Industry partner should show independent financial capabilities beyond grants received through this pilot.

 

Submission

By invitation only. NHIC will work with respective Cluster MHI Coordinating Parties to select and evaluate proposals. 

Innovations prioritised by your respective clusters can be submitted to NHIC for cross-cluster test-bedding. 

All applications must be endorsed by Cluster MHI CP and submitted by lead site to NHIC listed in the table below. Cluster MHI Coordinating Parties (Cluster MHI CP):

Healthcare Cluster MHI Coordinating Parties
NHG Health Centre for Healthcare Innovation – Grants & Innovation Office
National University Health System (NUHS) Group Digital Office
Singapore Health Services (SingHealth) SingHealth Office for Innovation

 

Contact person in NHIC

NHIC Grant Secretariat

Email: grant@nhic.cris.sg
 

Additional Information

Grant website link: Innovation to Adopt (I2Adopt)

NHIC I2A 2.0 Application Form